Access cutting-edge ulcerative colitis treatment through this clinical trial at a research site in Baltimore. Study-provided care at no cost to qualified participants.
Access ulcerative colitis specialists in Baltimore at no cost
This study follows strict safety protocols and ethical guidelines
All study-related ulcerative colitis treatment provided free
The study is an extension of two parent studies (MLN0002-3024 \[NCT04779307\] and MLN0002-3025 \[NCT04779320\]). Participants must have participated in one of the previous studies. The purpose of this study is to collect the long-term safety of vedolizumab in children with UC or CD.
Sponsor: Takeda
Check if you qualify for this ulcerative colitis clinical trial in Baltimore, MD
If you're searching for ulcerative colitis treatment options in Baltimore, MD, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Baltimore research site is actively enrolling participants for this clinical trial. You'll receive care from experienced ulcerative colitis specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.